Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q3 2021 call → NOWe need to determine if management's forward account is about counterparties' own growth trajectories that the company already serves, with early and large ramp ahead. Key points from transcript: - Management discusses state and federal partners, but mostly about contracts, expirations, and potential new contracts (e.g., Arizona RFP, Hawaii, West Tennessee, Leavenworth). These are prospects or ongoing negotiations, not already-served growth. - They mention ICE utilization increasing due to border activity, but that's a macro condition, not a specific counterparty's build-out. - They discuss staffing challenges and preparing for higher occupancy, but that's their own action. - They mention New Mexico lease conversion, but that's a one-off transaction, not a scaling trajectory. - No narrative of a specific customer's own expansion (like a retailer opening stores, a tech company rolling out) that the company is embedded in. The direction of explanation is about their own actions (deleveraging, staffing, contract negotiations) and general market conditions (COVID, border policy). No counterparty's own growth is described as early and large with the company already inside it. Thus answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.